SCHEMBL5611242

SCHEMBL5611242

CCCCCCCCCCC(CCCCC)OC(=O)/C=C\C(=O)OC(CCCCC)CCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.50
ATM Q13315 1/20 0.45
GPR84 Q9NQS5 5/20 0.44
FFAR1 O14842 1/20 0.44
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
ZDHHC7 Q9NXF8 1/20 0.43
MAPK1 P28482 1/20 0.43
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2833618 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL10385574 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL2100910 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL10897489 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL2831197 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL10387539 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL18209639 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL2101684 1.00 HCAR2 (0.50) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL10385861 0.98 HCAR2 (0.49) HCAR2ATMGPR84FFAR1LMNA
SCHEMBL2101143 0.98 HCAR2 (0.49) HCAR2ATMGPR84FFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1533322-B1 SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST TOHO TITANIUM CO LTD (JP) 2019-05-01 EP disclosed
US-9562119-B2 Ethylene polymerization catalysts W. R. GRACE & CO.-CONN. (US) 2017-02-07 US disclosed
EP-2576633-A2 ETHYLENE POLYMERIZATION CATALYSTS BASF Corporation (US) 2013-04-10 EP disclosed
US-20110294970-A1 ETHYLENE POLYMERIZATION CATALYSTS BASF CATALYSTS, LLC (US) 2011-12-01 US disclosed
WO-2011149656-A2 ETHYLENE POLYMERIZATION CATALYSTS BASF CORPORATION (US) 2011-12-01 WO disclosed
US-7208435-B2 Solid catalyst component for olefin polymerization and catalyst TOHO CATALYST CO., LTD. (JP) 2007-04-24 US disclosed
US-20050227856-A1 Solid catalyst component for olefin polymerization and catalyst TOHO CATALYST CO., LTD. (JP) 2005-10-13 US disclosed
EP-1533322-A1 SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST Toho Catalyst Co., Ltd. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294970-A1 ETHYLENE POLYMERIZATION CATALYSTS ESR1, MSMO1, MCM5 HCAR2 3524/4885ATM 44/4885GPR84 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.